Directory

>

Margaret Karow

avatar

Margaret Karow

Founder and Chief Development Office | Xilio Therapeutics, Inc.

Camarillo, California, United States

View contact details (it's free)

Margaret Karow

Summary

Margaret Karow is a seasoned biopharmaceutical expert with over 25 years of experience in protein therapeutics development. As the Founder and Chief Development Officer at Tentarix Biotherapeutics, she has a proven track record of leading innovative projects and achieving significant funding milestones. Her previous roles include serving as the Chief Scientific Officer at Gensun Biopharma and as Senior Vice President of Pre-Clinical Development at Xilio Therapeutics, where she played a pivotal role in advancing therapeutic candidates. Margaret's extensive background includes leadership positions at Amgen, where she oversaw various departments focused on biologics and biosimilars. She began her career at Regeneron, contributing to groundbreaking work in immunology and antibody development. Known for her strategic mindset and technical expertise, Margaret is passionate about advancing therapeutic solutions in the life sciences sector.

General

Specialist

Technical Background

Leadership Experience

Long-Term Tenure

Professional interests

Emerging Technologies

Leadership Development

Innovation

Organisational experience

Startup Experience

Corporate Experience

Margaret Karow

Work Experience

company logo

Founder and Chief Development Office at

Tentarix Biotherapeutics

February 2021 - Present

company logo

Special Advisor and Scientific Advisory Board member at

Xilio Therapeutics, Inc.

September 2019 - Present

💼

VICE PRESIDENT DISCOVERY AND PRECLINICAL DEVELOPMENT at

Akrevia Therapeutics

September 2016 - Present

company logo

Founder and Lead of Translational Biology at

Tentarix Biotherapeutics

August 2020 - February 2021

company logo

Senior Vice President of Pre-Clinical Development at

Xilio Therapeutics, Inc.

September 2016 - August 2020

company logo

Executive Director at

Amgen, Inc.

October 2014 - September 2016

company logo

Executive Director at

Amgen, Inc.

April 2006 - September 2016

company logo

Vice President at

Regeneron

January 1996 - January 2006

company logo

Immune Diseases and Antibody Therapeutics at

Regeneron Pharmaceuticals

January 1995 - January 2005

Logos provided by Logo.dev

Margaret Karow

Education

University of Utah School of Medicine, Phd

January 1987 - January 1992

University of Colorado Boulder, Bachelor Of Arts (B.A.)

January 1978 - January 1982

Frequently Asked Questions about Margaret Karow

What is Margaret Karow email address?

Margaret Karow's primary email address is ******@amgen.com. To view the full verified email and additional contact details, sign up for free with Muraena.

What company does Margaret Karow work for?

Margaret Karow is a Founder and Chief Development Office at Xilio Therapeutics, Inc., a company specializing in Commercial physical research.

Where Margaret Karow graduated from?

Margaret Karow holds a degree in Cvm Biology from University of Utah School of Medicine.

How can I directly contact Margaret Karow?

To contact Margaret Karow directly, you can use the email address ******@amgen.com. Complete contact information is available upon registration with Muraena.

Who is Margaret Karow?

Margaret Karow is a seasoned biopharmaceutical expert with over 25 years of experience in protein therapeutics development. As the Founder and Chief Development Officer at Tentarix Biotherapeutics, she has a proven track record of leading innovative projects and achieving significant funding milestones. Her previous roles include serving as the Chief Scientific Officer at Gensun Biopharma and as Senior Vice President of Pre-Clinical Development at Xilio Therapeutics, where she played a pivotal role in advancing therapeutic candidates. Margaret's extensive background includes leadership positions at Amgen, where she oversaw various departments focused on biologics and biosimilars. She began her career at Regeneron, contributing to groundbreaking work in immunology and antibody development. Known for her strategic mindset and technical expertise, Margaret is passionate about advancing therapeutic solutions in the life sciences sector.

Margaret`s contact details

mail

******@amgen.com

******@tentarix.com

Colleagues

avatar
Sean Ring

Senior Vice President, Corporate Development and Program Leadership

avatar
Teleen Norman

Senior Vice President Clinical Operations

avatar
Fraser Leslie

Senior Vice President Tech Ops

avatar
Rene Russo

Director

avatar
Scott Coleman

Chief Development Officer (CDO)

avatar
Scott Mcconnell

Vice President Clinical Science and Pharmacovigilance

avatar
Katarina Luptakova

Chief Medical Officer

avatar
Carl Uli Bialucha

Chief Scientific Officer

avatar
Christopher Frankenfield

Chief Financial Officer and Chief Operating Officer

View Contact details (it's free)
Request Profile Removal